ThermoGenesis Holdings, Inc.
(NASDAQ : THMO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.00%415.721.0%$499.55m
DHRDanaher Corp. 0.62%206.970.7%$493.25m
INOInovio Pharmaceuticals, Inc. 1.13%20.566.3%$471.41m
ABTAbbott Laboratories 0.19%101.940.8%$469.86m
ISRGIntuitive Surgical, Inc. -0.30%689.202.4%$464.65m
MDTMedtronic Plc 1.70%98.370.6%$446.91m
DXCMDexCom, Inc. 3.42%453.997.9%$411.76m
BSXBoston Scientific Corp. 1.56%38.481.1%$333.80m
BDXBecton, Dickinson & Co. -0.17%259.171.0%$318.40m
SYKStryker Corp. 1.61%191.621.3%$267.09m
ALGNAlign Technology, Inc. 1.00%304.816.4%$266.97m
VARVarian Medical Systems, Inc. -0.03%173.049.1%$253.65m
BAXBaxter International, Inc. -0.24%80.181.8%$245.87m
EWEdwards Lifesciences Corp. -0.47%77.050.4%$210.48m
QDELQuidel Corp. -1.27%281.737.7%$209.37m

Company Profile

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.